[{"Assets_0_Q2_USD":852799000.0,"CommonStockSharesOutstanding_0_Q2_shares":52179334.0,"EarningsPerShareBasic_2_Q2_USD":1.1,"EarningsPerShareBasic_1_Q2_USD":0.59,"EarningsPerShareDiluted_2_Q2_USD":1.06,"EarningsPerShareDiluted_1_Q2_USD":0.57,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":33689000.0,"NetIncomeLoss_2_Q2_USD":57089000.0,"NetIncomeLoss_1_Q2_USD":30737000.0,"StockholdersEquity_0_Q2_USD":390492000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":54021941.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":54203308.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":51729243.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":51919894.0,"Ticker":"SUPN","CIK":"1356576","name":"SUPERNUS PHARMACEUTICALS INC","OfficialName":"Supernus Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20180630","fy":"2018.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1557812380.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20180809"}]